Psilocybin Therapy in Advanced Cancer

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Advanced Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Colorado Anschutz Medical campus (CU AMC), Aurora, Colorado, United States
Contact: Study coordinator (Stacy Fischer, MD) · Stacy.Fischer@cuanschutz.edu · 303-724-2406
Contact: Study coordinator (Mary Mancuso) · mary.mancuso@cuanschutz.edu · 303-724-5729
Contact: Principal Investigator (Stacy Fischer, MD)
NYU Langone Health, New York, New York, United States
Contact: Study coordinator (Sydney Weiner, MA) · sydney.weiner@nyulangone.org · 212-263-6283
Contact: Study coordinator (Stephen Ross, MD) · stephen.ross@nyulangone.org · 212-263-6289
Contact: Principal Investigator (Stephen Ross, MD)

Study leads

Stephen Ross, MD
Principal Investigator
NYU Langone Medical Center

View source on ClinicalTrials.gov